From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC

被引:14
作者
Protopapa, Maria [1 ]
Kouloulias, Vassilis [2 ]
Nikoloudi, Styliani [1 ]
Papadimitriou, Christos [3 ]
Gogalis, Giannis [1 ]
Zygogianni, Anna [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Aretaie Univ Hosp, Med Sch, Radiat Oncol Unit,Dept Radiol 1, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Gen Hosp, Med Sch, Radiat Oncol Unit,Dept Radiol 2, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Aretaie Univ Hosp Athens, Med Sch, Med Oncol Unit,Surg Clin 2, Athens, Greece
关键词
CELL-LUNG-CANCER; CENTRAL-NERVOUS-SYSTEM; POSTOPERATIVE STEREOTACTIC RADIOSURGERY; GRADED PROGNOSTIC ASSESSMENT; TYROSINE KINASE INHIBITORS; PROGRAMMED-DEATH; RADIATION-THERAPY; OPEN-LABEL; PHASE-III; SECONDARY ANALYSIS;
D O I
10.1155/2019/3267409
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-small cell lung cancer patients with brain metastases have a multitude of treatment options, but there is currently no international and multidisciplinary consensus concerning their optimal treatment. Local therapies have the principal role, especially in symptomatic patients. Advances in surgery and radiation therapy manage considerable local control. Systemic treatments have shown effect in clinical trials and in real life clinical settings; yet, at present, this is restricted to patients with asymptomatic or stable intracranial lesions. Targeted agents can have a benefit only in patients with EGFR mutations or ALK rearrangement. Immunotherapy has shown impressive results in patients with PD-L1 expression in tumor cells. Its effects can be further enhanced by a synergy with radiotherapy, possibly by increasing the percentage of responders. The present review summarizes the need for more effective systemic treatments, so that the increased intracranial control achieved by local treatments can be translated in an increase in overall survival.
引用
收藏
页数:12
相关论文
共 147 条
[1]   Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination [J].
Aboudaram, Amelie ;
Modesto, Anouchka ;
Chaltiel, Leonor ;
Gomez-Roca, Carlos ;
Boulinguez, Serge ;
Sibaud, Vincent ;
Delord, Jean-Pierre ;
Chira, Ciprian ;
Delannes, Martine ;
Moyal, Elizabeth ;
Meyer, Nicolas .
MELANOMA RESEARCH, 2017, 27 (05) :485-491
[2]   A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer [J].
Afzal, Muhammad Zubair ;
Dragnev, Konstantin ;
Shirai, Keisuke .
JOURNAL OF THORACIC DISEASE, 2018, 10 (06) :3575-3584
[3]   The origin of brain metastases in patients with an undiagnosed primary tumour [J].
Agazzi, S ;
Pampallona, S ;
Pica, A ;
Vernet, O ;
Regli, L ;
Porchet, F ;
Villemure, JG ;
Leyvraz, S .
ACTA NEUROCHIRURGICA, 2004, 146 (02) :153-157
[4]   Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases [J].
Ahmed, Kamran A. ;
Kim, Sungjune ;
Arrington, John ;
Naghavi, Arash O. ;
Dilling, Thomas J. ;
Creelan, Ben C. ;
Antonia, Scott J. ;
Caudell, Jimmy J. ;
Harrison, Louis B. ;
Sahebjam, Solmaz ;
Gray, Jhanelle E. ;
Etame, Arnold B. ;
Johnstone, Peter A. ;
Yu, Michael ;
Perez, Bradford A. .
JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (02) :331-338
[5]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[6]  
[Anonymous], J NATL CANC I
[7]   Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Yokoi, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
de Castro Carpeno, J. ;
Wadsworth, C. ;
Melillo, G. ;
Jiang, H. ;
Huang, Y. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) :1919-1929
[8]   Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial [J].
Aoyama, Hidefumi ;
Shirato, Hiroki ;
Tago, Masao ;
Nakagawa, Keiichi ;
Toyoda, Tatsuya ;
Hatano, Kazuo ;
Kenjyo, Masahiro ;
Oya, Natsuo ;
Hirota, Saeko ;
Shioura, Hiroki ;
Kunieda, Etsuo ;
Inomata, Taisuke ;
Hayakawa, Kazushige ;
Katoh, Norio ;
Kobashi, Gen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2483-2491
[9]   Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial [J].
Aoyama, Hidefumi ;
Tago, Masao ;
Shirato, Hiroki .
JAMA ONCOLOGY, 2015, 1 (04) :457-464
[10]   Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer [J].
Arbour, Kathryn C. ;
Mezquita, Laura ;
Long, Niamh ;
Rizvi, Hira ;
Auclin, Edouard ;
Ni, Andy ;
Martinez-Bernal, Gala ;
Ferrara, Roberto ;
Lai, W. Victoria ;
Hendriks, Lizza E. L. ;
Sabari, Joshua K. ;
Caramella, Caroline ;
Plodkowski, Andrew J. ;
Halpenny, Darragh ;
Chaft, Jamie E. ;
Planchard, David ;
Riely, Gregory J. ;
Besse, Benjamin ;
Hellmann, Matthew D. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (28) :2872-+